Cedrik Britten

Company: Immatics

Job title: Chief Medical Officer

Seminars:

Panel Discussion: Leveraging Clinical Results to Drive Investment in Your Product 12:30 pm

• What are the biggest challenges that the development of next-generation cell therapies face? • How do we overcome these challenges? • What clinical outcomes are the most important to drive investment?Read more

day: Day 1 – Track B – Morning

ACTengine® IMA203 TCR-T to Treat Patients with PRAME-Positive Solid Cancers 2:00 pm

• Leveraging TCR-T cells for a broad variety of hard-to-treat solid cancers • Optimising patient selection for autologous cell therapies • Outlining steps to continuously improve the clinical development strategy • Exploring next-generation product candidatesRead more

day: Day 2 - Track B - Afternoon